查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2120884

全球生物製造材料市場預測至2034年：按材料類型、生醫材料化學、生物製造技術、生物列印技術、生物墨水類型、細胞來源、生物製造組織、應用、最終用戶和地區分類

Biofabrication Materials Market Forecasts To 2034 - Global Analysis By Material Type, Biomaterial Chemistry, Biofabrication Technology, Bioprinting Technology, Bioink Type, Cell Source, Biofabricated Tissue, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球生物製造材料市場規模將達到 99 億美元，並在預測期內以 11.0% 的複合年成長率成長，到 2034 年將達到 228 億美元。

生物製造材料市場專注於先進材料，這些材料能夠利用生物製造和生物列印技術來建立活體組織、生物結構和逼真的組織模型。該市場涵蓋水凝膠、天然和合成聚合物、膠原蛋白、膠原蛋白、多醣以及混合生醫材料，旨在提供適合細胞增殖和組織發育的環境。這些材料在再生醫學、組織工程、藥物測試、疾病建模和晶片器官系統中的日益廣泛應用，正在創造新的機會。生醫材料性能、結構控制和生物相容性的不斷提升，正在加速創新。醫療領域的投資增加、個人化醫療的發展以及減少動物實驗的舉措，也推動了市場的擴張。

在藥物發現和疾病建模的應用日益廣泛

藥物研發中3D生物模型的日益普及推動了對生物製造材料的需求。生物列印組織、類器官和晶片器官系統能夠比傳統的2D培養更真實地再現人體組織的結構特徵。這使得這些模型在闡明疾病機制、篩檢候選藥物和評估毒性方面發揮著極其重要的作用。生物墨水和生醫材料載體提供了維持細胞和重現相關生物學條件所需的結構環境。因此，製藥和生物技術公司越來越關注能夠提高預測準確性和研究效率的高度人體相關性測試系統。由此可見，向先進體外模型的轉變正在拓展生物製造材料供應商的應用範圍和商業性機會。

生物製造材料和製造高成本

高昂的材料成本和生產要求會限制生物製造材料市場的擴張。許多先進配方依賴昂貴的成分，例如膠原蛋白、細胞外基質衍生物、生長因子和高度專業化的聚合物。此外，維持無菌生產環境、純化、品質檢測和生產流程驗證都會產生額外的成本。特別是商業規模的生產面臨許多挑戰，因為材料必須在滿足嚴格的安全和品質要求的同時，以保持性能的穩定性。這些要求使得小規模實驗室和研究機構難以獲得先進的生物墨水和生醫材料。因此，高昂的材料和生產成本會導致應用延遲和擴充性，這可能阻礙有前景的生物製造材料從研究走向更廣泛的商業性和臨床應用。

再生醫學的應用範圍不斷擴大

再生醫學領域投資的不斷成長為生物製造材料製造商帶來了巨大的機會。先進的水凝膠、膠原蛋白製劑、細胞外基質衍生材料和生物活性聚合物能夠幫助修復受損組織。研究正日益聚焦於骨骼、軟骨、皮膚、肌肉、血管和其他複雜生物結構等應用領域。這項進展正在加速開發具有優異細胞相容性、可控分解性、結構穩定性和可列印性的材料。新型3D和4D列印技術也對先進的生醫材料配方提出了新的要求。隨著再生醫學朝著個人化治療和臨床實用組織結構的方向發展，對專用生物墨水和生物製造材料的需求預計將顯著成長。

與供應鏈和原料供應相關的風險

生物製造材料生產商極易受到供應風險的影響，因為其許多產品依賴特殊的生物和化學原料。膠原蛋白、明膠、藻酸鹽、細胞外基質成分、生長因子和先進聚合物等原料的採購和加工都需要精細的管理。此外，生物來源材料的純度和成分可能因批次而異，這給品管帶來了額外的挑戰。供不應求、供應商中斷、採購要求的變化或原料價格上漲都可能推高生產成本並減少供應。依賴有限供應商的公司尤其容易受到供應中斷的影響。這些情況會影響生產的穩定性，推高價格，阻礙大規模生產，並最終限制生物製造材料供應商滿足日益成長的商業性和醫療需求的能力。

新型冠狀病毒（COVID-19）的影響：

新冠疫情初期，實驗室關閉、研究人員進入受限、供應鏈中斷以及實驗工程延誤等問題，對生物製造材料市場造成了衝擊。由於醫療系統和研究機構優先應對疫情，許多涉及生醫材料、組織工程和生物列印的項目被迫延期。資金也被轉移到新冠病毒研究，導致其他生物醫學研究的資源暫時減少。然而，這場危機凸顯了創新醫療技術的重要性，並激發了人們對3D生物模型和先進研究平台的興趣。生物製造技術在感染疾病研究和人體試驗中展現了其巨大潛力。隨著實驗室運作的恢復和生物醫學投資的回升，生物墨水、水凝膠和其他生物製造材料的研發再次進入成長軌道。

在預測期內，「天然生醫材料」細分市場預計將佔據最大的市場佔有率。

預計在預測期內，天然生醫材料將佔據最大的市場佔有率，這主要得益於天然材料固有的生物相容性和類似細胞外基質的特性。膠原蛋白、明膠、藻酸鹽、纖維蛋白和透明質酸因其能夠支持細胞黏附、增殖、分化和組織發育而被廣泛應用。它們在實驗室研發和臨床前生物製造領域的穩固​​地位進一步推動了其應用。天然生醫材料能夠提供與活體組織非常接近的生物環境，從而支持人工結構內的細胞功能。因此，它們在組織工程、再生醫學、疾病建模和3D組織建構等領域的適用性進一步鞏固了其在生物製造材料領域的主導地位。

預計在預測期內，「晶片器官」細分市場將呈現最高的複合年成長率。

在預測期內，「晶片器官」細分市場預計將呈現最高的成長率，這主要得益於人們對能夠複製人體生理功能關鍵方面的高級生物模型的日益成長的興趣。水凝膠、細胞外基質材料和特製生物墨水為在這些系統中建立功能性組織模型提供了必要的細胞環境。製藥和生物技術公司在藥物發現、毒性測試、疾病研究和個人化醫療等領域的應用不斷拓展，進一步擴大了晶片器官的應用範圍。微流體、生物列印和生醫材料配方技術的進步，使得建構日益複雜且生物學上可重複的平台成為可能。隨著晶片器官技術的日益成熟和應用日益廣泛，針對特定組織和生物功能量身定做的生物製造材料的需求預計將會增加。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其成熟的生命科學生態系統和先進的生物醫學研究能力。對生物列印、再生醫學、組織工程和藥物研發的大力投資正在推動特種生物墨水、水凝膠和生醫材料的應用。該地區還受益於學術機構、生物技術公司、製藥公司和醫療保健機構之間的密切合作，從而支持技術的持續發展。美國憑藉其完善的研究基礎設施、資金籌措環境以及生物製造領域企業的集中度，仍然是該地區的主要貢獻者。這些優勢的結合，鞏固了北美在生物製造材料領域的領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於生物技術能力的快速發展以及對再生醫學和組織工程研究投入的增加。包括中國、日本、韓國、印度和新加坡在內的國家正在加強其科學基礎設施建設，並推動生物列印和先進生醫材料技術的應用。政府舉措、生命科學領域資金投入的增加以及大學、研究機構和行業相關人員之間的合作正在推動整個全部區域的創新。此外，醫療保健體系的改善、製藥活動的擴張以及良好的生產環境也促進了生物製造材料的應用。因此，預計全部區域對生物墨水、水凝膠和特殊生醫材料的需求將顯著成長。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管/政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球生物製造材料市場：依材料類型分類

  • 天然生醫材料
  • 合成生醫材料
  • 混合生醫材料
  • 生物活性生醫材料
  • 去細胞細胞外基質材料
  • 細胞衍生生醫材料

第6章 全球生物製造材料市場：依生醫材料化學分類

  • 水凝膠
  • 天然聚合物
  • 合成聚合物
  • 蛋白質
  • 胜肽
  • 多醣
  • 陶瓷
  • 複合材料

第7章 全球生物製造材料市場：依生物製造技術分類

  • 3D生物列印
  • 4D生物列印
  • 生物組裝
  • 細胞片層工程
  • 微流體生物製造
  • 靜電紡絲

第8章 全球生物製造材料市場：依生物列印技術分類

  • 擠出式生物列印
  • 噴墨生物列印
  • 雷射輔助生物列印
  • 基於SLA的生物列印
  • DLP生物列印
  • 基於體積的生物列印

第9章 全球生物製造材料市場：依生物墨水類型分類

  • 天然聚合物基生物墨水
  • 合成聚合物基生物墨水
  • 去細胞基質生物墨水
  • 蛋白質生物墨水
  • 多醣體生物墨水
  • 複合生物墨水
  • 含細胞生物墨水

第10章 全球生物製造材料市場：依支架類型分類

  • 水凝膠支架
  • 多孔聚合物支架
  • 去細胞支架
  • 陶瓷支架
  • 複合支架
  • 奈米纖維支架

第11章 全球生物製造材料市場：依細胞來源分類

  • 自體細胞
  • 同種異體細胞
  • 外來細胞
  • 原代細胞
  • 幹細胞
  • 誘導性多能幹細胞
  • 前驅細胞
  • 細胞株

第12章 全球生物製造材料市場：依細胞類型分類

  • 間質幹細胞
  • ES細胞
  • 神經細胞
  • 心肌細胞
  • 肝細胞
  • 軟骨細胞
  • 成骨細胞
  • 內皮細胞
  • 纖維母細胞
  • 上皮細胞
  • 免疫細胞

第13章 全球生物製造材料市場：依生物製造組織分類

  • 皮膚
  • 骨
  • 軟骨
  • 肌肉
  • 神經組織
  • 心血管組織
  • 肝組織
  • 腎臟組織
  • 胰臟組織
  • 肺組織
  • 胃腸道組織
  • 角膜組織
  • 血管組織

第14章 全球生物製造材料市場：依材料特性分類

  • 生物相容性
  • 可生物分解
  • 生物活性
  • 機械強度
  • 細胞黏附
  • 細胞增殖
  • 細胞分化能力
  • 分解可控性
  • 刺激反應性

第15章 全球生物製造材料市場：依應用領域分類

  • 組織工程
  • 再生醫學
  • 藥物發現與開發
  • 疾病建模
  • Organ-on-a-Chip
  • 個人化醫療
  • 基於細胞的檢測
  • 創傷治療
  • 移植

第16章 全球生物製造材料市場：依最終用戶分類

  • 製藥和生物技術公司
  • 學術和研究機構
  • 醫院和醫療中心
  • CRO
  • 醫療設備製造商
  • 組織工程公司

第17章 全球生物製造材料市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第18章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第19章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第20章：公司簡介

  • CELLINK
  • CollPlant Biotechnologies Ltd.
  • Advanced BioMatrix
  • Allevi, Inc.
  • BIO INX
  • Humabiologics, Inc.
  • UPM Biomedicals
  • Viscofan Bioengineering
  • Inventia Life Science
  • Axolotl Biosciences
  • Foldink
  • Merck KGaA
  • TheWell Bioscience
  • VoxCell BioInnovation
  • Gelomics Pty Ltd.
  • QGel SA
  • INNOREGEN
  • Scire Science
Product Code: SMRC39154

According to Stratistics MRC, the Global Biofabrication Materials Market Market is accounted for $9.9 billion in 2026 and is expected to reach $22.8 billion by 2034 growing at a CAGR of 11.0% during the forecast period. The Biofabrication Materials Market focuses on advanced materials that enable the fabrication of living tissues, biological structures, and realistic tissue models using biofabrication and bioprinting techniques. The market includes hydrogels, natural and synthetic polymers, collagen, proteins, polysaccharides, and hybrid biomaterials engineered to provide suitable environments for cellular growth and tissue development. Increasing use of these materials in regenerative medicine, tissue engineering, drug testing, disease modeling, and organ-on-chip systems is creating new opportunities. Continuous improvements in biomaterial performance, structural control, and biological compatibility are accelerating innovation. Rising healthcare investment, personalized medicine initiatives, and efforts to reduce animal testing are also contributing to market expansion.

Market Dynamics:

Driver:

Increasing Use in Drug Discovery and Disease Modeling

Increasing adoption of three-dimensional biological models for pharmaceutical research is strengthening demand for biofabrication materials. Bioprinted tissues, organoids, and organ-on-chip systems can more closely reproduce aspects of human tissue architecture than traditional two-dimensional cultures. This makes them valuable for investigating disease mechanisms, screening drug candidates, and evaluating toxicity. Bioinks and supporting biomaterials provide the structural environment necessary to maintain cells and reproduce relevant biological conditions. Pharmaceutical and biotechnology companies are therefore expanding interest in human-relevant testing systems that can improve predictive accuracy and research productivity. The shift toward advanced in-vitro models is consequently broadening the applications and commercial opportunities for biofabrication material suppliers.

Restraint:

High Cost of Biofabrication Materials and Production

Expensive materials and manufacturing requirements can limit the expansion of the Biofabrication Materials Market. Many advanced formulations depend on costly components such as collagen, extracellular matrix derivatives, growth factors, and highly specialized polymers. Additional expenses arise from maintaining sterile manufacturing environments, conducting purification, performing quality testing, and validating production processes. Commercial-scale manufacturing is particularly challenging because materials must maintain consistent properties while meeting stringent safety and quality requirements. These requirements can make sophisticated bioinks and biomaterials unaffordable for smaller laboratories and research institutions. Consequently, high material and manufacturing costs may slow adoption, restrict scalability, and delay the transition of promising biofabrication materials from research settings toward broader commercial and clinical applications.

Opportunity:

Expansion of Regenerative Medicine Applications

Growing investment in regenerative medicine is opening substantial opportunities for biofabrication-material manufacturers. Advanced hydrogels, collagen formulations, extracellular matrix-derived materials, and bioactive polymers can support the formation and restoration of damaged tissues. Research is increasingly targeting applications involving bone, cartilage, skin, muscle, blood vessels, and other complex biological structures. This progress is encouraging development of materials offering better cellular compatibility, controlled degradation, structural stability, and printing performance. Emerging 3D and 4D fabrication approaches are also creating new requirements for sophisticated biomaterial formulations. As regenerative medicine moves toward personalized treatments and clinically useful tissue constructs, demand for specialized bioinks and biofabrication materials is expected to expand considerably.

Threat:

Supply Chain and Raw Material Availability Risks

Biofabrication-material manufacturers can be exposed to supply risks because many products depend on specialized biological and chemical inputs. Collagen, gelatin, alginate, extracellular matrix components, growth factors, and advanced polymers may require carefully controlled sourcing and processing. Biological materials can also vary in purity and composition between batches, creating additional quality-control challenges. Shortages, supplier disruptions, changing sourcing requirements, or increases in raw-material prices could raise production expenses and reduce availability. Companies relying on limited suppliers may be particularly vulnerable to disruptions. These conditions could affect manufacturing consistency, increase prices, complicate large-scale production, and ultimately restrict the ability of biofabrication-material suppliers to meet growing commercial and healthcare demand.

Covid-19 Impact:

COVID-19 initially disrupted the Biofabrication Materials Market through laboratory shutdowns, restricted researcher access, supply-chain interruptions, and delays in experimental programs. Many projects involving biomaterials, tissue engineering, and bioprinting experienced slower progress as healthcare systems and research institutions prioritized the pandemic. Funding was also redirected toward COVID-19 investigations, temporarily limiting resources available for unrelated biomedical research. Nevertheless, the crisis highlighted the importance of innovative healthcare technologies and increased interest in three-dimensional biological models and advanced research platforms. Biofabrication technologies demonstrated potential for infection research and human-relevant testing. Following the restoration of laboratory operations and biomedical investment, development of bioinks, hydrogels, and other biofabrication materials resumed growth.

The Natural Biomaterials segment is expected to be the largest during the forecast period

The Natural Biomaterials segment is expected to account for the largest market share during the forecast period, driven by the inherent biological compatibility and extracellular-matrix-like properties of naturally sourced materials. Collagen, gelatin, alginate, fibrin, and hyaluronic acid are widely utilized because they can support cellular attachment, growth, differentiation, and tissue development. Their established presence in laboratory research and preclinical biofabrication further strengthens their adoption. Natural biomaterials provide biological environments that can closely resemble native tissue conditions, supporting cell functionality within engineered structures. Consequently, their suitability for tissue engineering, regenerative medicine, disease modeling, and three-dimensional tissue fabrication continues to reinforce their leading position within the biofabrication materials landscape.

The Organ-on-a-Chip segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Organ-on-a-Chip segment is predicted to witness the highest growth rate, supported by rising interest in sophisticated biological models capable of reproducing important aspects of human physiology. Hydrogels, extracellular matrix materials, and specialized bioinks provide the cellular environments required to construct functional tissue models within these systems. Growing utilization by pharmaceutical and biotechnology organizations for drug development, toxicity testing, disease investigation, and personalized healthcare is expanding the application base. Progress in microfluidics, bioprinting, and biomaterial formulation is enabling increasingly complex and biologically representative platforms. As organ-on-a-chip technologies become more advanced and widely adopted, demand for customized biofabrication materials designed for specific tissues and biological functions is expected to increase.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by its mature life sciences ecosystem and advanced biomedical research capabilities. Strong investment in bioprinting, regenerative medicine, tissue engineering, and pharmaceutical research is encouraging adoption of specialized bioinks, hydrogels, and biomaterials. The region also benefits from close cooperation between academic institutions, biotechnology companies, pharmaceutical organizations, and healthcare providers, supporting continuous technological development. The United States remains the primary contributor because of its extensive research infrastructure, funding environment, and concentration of companies involved in biofabrication. Together, these advantages reinforce North America's leadership in biofabrication materials.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by rapid expansion of biotechnology capabilities and increasing investment in regenerative medicine and tissue engineering research. Nations including China, Japan, South Korea, India, and Singapore are strengthening scientific infrastructure and promoting the adoption of bioprinting and advanced biomaterial technologies. Government initiatives, rising funding for life sciences, and collaborations between universities, research organizations, and industry participants are fostering innovation across the region. In addition, improving healthcare systems, expanding pharmaceutical activities, and favorable manufacturing environments are contributing to greater utilization of biofabrication materials. Consequently, demand for bioinks, hydrogels, and specialized biomaterials is expected to rise significantly across Asia-Pacific.

Key players in the market

Some of the key players in Biofabrication Materials Market include CELLINK, CollPlant Biotechnologies Ltd., Advanced BioMatrix, Allevi, Inc., BIO INX, Humabiologics, Inc., UPM Biomedicals, Viscofan Bioengineering, Inventia Life Science, Axolotl Biosciences, Foldink, Merck KGaA, TheWell Bioscience, VoxCell BioInnovation, Gelomics Pty Ltd., QGel SA, INNOREGEN, Scire Science.

Key Developments:

In May 2026, BIO INX announced a new partnership with MP Strumenti, appointing the company as its official distributor in Italy. The agreement covers BIO INX's portfolio of biomaterials for extrusion-based printing, DLP, volumetric bioprinting, and multiphoton lithography, supporting tissue engineering, regenerative medicine, drug-discovery models, and precision medicine.

In November 2025, Humabiologics announced its expansion to Winston-Salem's Innovation Quarter and stated that the new facility would focus on collaborative product development, clinical translation, and early-stage manufacturing in partnership with regional institutions, including WFIRM.

Material Types Covered:

  • Natural Biomaterials
  • Synthetic Biomaterials
  • Hybrid Biomaterials
  • Bioactive Biomaterials
  • Decellularized Extracellular Matrix Materials
  • Cell-Derived Biomaterials

Biomaterial Chemistries Covered:

  • Hydrogels
  • Natural Polymers
  • Synthetic Polymers
  • Proteins
  • Peptides
  • Polysaccharides
  • Ceramics
  • Composite Materials

Biofabrication Technologies Covered:

  • 3D Bioprinting
  • 4D Bioprinting
  • Bioassembly
  • Cell Sheet Engineering
  • Microfluidic Biofabrication
  • Electrospinning

Bioprinting Technologies Covered:

  • Extrusion-Based Bioprinting
  • Inkjet-Based Bioprinting
  • Laser-Assisted Bioprinting
  • Stereolithography-Based Bioprinting
  • Digital Light Processing Bioprinting
  • Volumetric Bioprinting

Bioink Types Covered:

  • Natural Polymer-Based Bioinks
  • Synthetic Polymer-Based Bioinks
  • Decellularized Matrix-Based Bioinks
  • Protein-Based Bioinks
  • Polysaccharide-Based Bioinks
  • Composite Bioinks
  • Cell-Laden Bioinks

Scaffold Types Covered:

  • Hydrogel Scaffolds
  • Porous Polymer Scaffolds
  • Decellularized Scaffolds
  • Ceramic Scaffolds
  • Composite Scaffolds
  • Nanofibrous Scaffolds

Cell Sources Covered:

  • Autologous Cells
  • Allogeneic Cells
  • Xenogeneic Cells
  • Primary Cells
  • Stem Cells
  • Induced Pluripotent Stem Cells
  • Progenitor Cells
  • Cell Lines

Cell Types Covered:

  • Mesenchymal Stem Cells
  • Embryonic Stem Cells
  • Neural Cells
  • Cardiomyocytes
  • Hepatocytes
  • Chondrocytes
  • Osteoblasts
  • Endothelial Cells
  • Fibroblasts
  • Epithelial Cells
  • Immune Cells

Biofabricated Tissues Covered:

  • Skin
  • Bone
  • Cartilage
  • Muscle
  • Neural Tissue
  • Cardiovascular Tissue
  • Liver Tissue
  • Kidney Tissue
  • Pancreatic Tissue
  • Lung Tissue
  • Gastrointestinal Tissue
  • Corneal Tissue
  • Vascular Tissue

Material Properties Covered:

  • Biocompatibility
  • Biodegradability
  • Bioactivity
  • Mechanical Strength
  • Cell Adhesion
  • Cell Proliferation
  • Cell Differentiation
  • Controlled Degradation
  • Stimuli Responsiveness

Applications Covered:

  • Tissue Engineering
  • Regenerative Medicine
  • Drug Discovery and Development
  • Disease Modeling
  • Organ-on-a-Chip
  • Personalized Medicine
  • Cell-Based Assays
  • Wound Healing
  • Transplantation

End Users Covered:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Medical Centers
  • Contract Research Organizations
  • Medical Device Companies
  • Tissue Engineering Companies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biofabrication Materials Market, By Material Type

  • 5.1 Natural Biomaterials
  • 5.2 Synthetic Biomaterials
  • 5.3 Hybrid Biomaterials
  • 5.4 Bioactive Biomaterials
  • 5.5 Decellularized Extracellular Matrix Materials
  • 5.6 Cell-Derived Biomaterials

6 Global Biofabrication Materials Market, By Biomaterial Chemistry

  • 6.1 Hydrogels
  • 6.2 Natural Polymers
  • 6.3 Synthetic Polymers
  • 6.4 Proteins
  • 6.5 Peptides
  • 6.6 Polysaccharides
  • 6.7 Ceramics
  • 6.8 Composite Materials

7 Global Biofabrication Materials Market, By Biofabrication Technology

  • 7.1 3D Bioprinting
  • 7.2 4D Bioprinting
  • 7.3 Bioassembly
  • 7.4 Cell Sheet Engineering
  • 7.5 Microfluidic Biofabrication
  • 7.6 Electrospinning

8 Global Biofabrication Materials Market, By Bioprinting Technology

  • 8.1 Extrusion-Based Bioprinting
  • 8.2 Inkjet-Based Bioprinting
  • 8.3 Laser-Assisted Bioprinting
  • 8.4 Stereolithography-Based Bioprinting
  • 8.5 Digital Light Processing Bioprinting
  • 8.6 Volumetric Bioprinting

9 Global Biofabrication Materials Market, By Bioink Type

  • 9.1 Natural Polymer-Based Bioinks
  • 9.2 Synthetic Polymer-Based Bioinks
  • 9.3 Decellularized Matrix-Based Bioinks
  • 9.4 Protein-Based Bioinks
  • 9.5 Polysaccharide-Based Bioinks
  • 9.6 Composite Bioinks
  • 9.7 Cell-Laden Bioinks

10 Global Biofabrication Materials Market, By Scaffold Type

  • 10.1 Hydrogel Scaffolds
  • 10.2 Porous Polymer Scaffolds
  • 10.3 Decellularized Scaffolds
  • 10.4 Ceramic Scaffolds
  • 10.5 Composite Scaffolds
  • 10.6 Nanofibrous Scaffolds

11 Global Biofabrication Materials Market, By Cell Source

  • 11.1 Autologous Cells
  • 11.2 Allogeneic Cells
  • 11.3 Xenogeneic Cells
  • 11.4 Primary Cells
  • 11.5 Stem Cells
  • 11.6 Induced Pluripotent Stem Cells
  • 11.7 Progenitor Cells
  • 11.8 Cell Lines

12 Global Biofabrication Materials Market, By Cell Type

  • 12.1 Mesenchymal Stem Cells
  • 12.2 Embryonic Stem Cells
  • 12.3 Neural Cells
  • 12.4 Cardiomyocytes
  • 12.5 Hepatocytes
  • 12.6 Chondrocytes
  • 12.7 Osteoblasts
  • 12.8 Endothelial Cells
  • 12.9 Fibroblasts
  • 12.10 Epithelial Cells
  • 12.11 Immune Cells

13 Global Biofabrication Materials Market, By Biofabricated Tissue

  • 13.1 Skin
  • 13.2 Bone
  • 13.3 Cartilage
  • 13.4 Muscle
  • 13.5 Neural Tissue
  • 13.6 Cardiovascular Tissue
  • 13.7 Liver Tissue
  • 13.8 Kidney Tissue
  • 13.9 Pancreatic Tissue
  • 13.10 Lung Tissue
  • 13.11 Gastrointestinal Tissue
  • 13.12 Corneal Tissue
  • 13.13 Vascular Tissue

14 Global Biofabrication Materials Market, By Material Property

  • 14.1 Biocompatibility
  • 14.2 Biodegradability
  • 14.3 Bioactivity
  • 14.4 Mechanical Strength
  • 14.5 Cell Adhesion
  • 14.6 Cell Proliferation
  • 14.7 Cell Differentiation
  • 14.8 Controlled Degradation
  • 14.9 Stimuli Responsiveness

15 Global Biofabrication Materials Market, By Application

  • 15.1 Tissue Engineering
  • 15.2 Regenerative Medicine
  • 15.3 Drug Discovery and Development
  • 15.4 Disease Modeling
  • 15.5 Organ-on-a-Chip
  • 15.6 Personalized Medicine
  • 15.7 Cell-Based Assays
  • 15.8 Wound Healing
  • 15.9 Transplantation

16 Global Biofabrication Materials Market, By End User

  • 16.1 Pharmaceutical and Biotechnology Companies
  • 16.2 Academic and Research Institutes
  • 16.3 Hospitals and Medical Centers
  • 16.4 Contract Research Organizations
  • 16.5 Medical Device Companies
  • 16.6 Tissue Engineering Companies

17 Global Biofabrication Materials Market, By Geography

  • 17.1 North America
    • 17.1.1 United States
    • 17.1.2 Canada
    • 17.1.3 Mexico
  • 17.2 Europe
    • 17.2.1 United Kingdom
    • 17.2.2 Germany
    • 17.2.3 France
    • 17.2.4 Italy
    • 17.2.5 Spain
    • 17.2.6 Netherlands
    • 17.2.7 Belgium
    • 17.2.8 Sweden
    • 17.2.9 Switzerland
    • 17.2.10 Poland
    • 17.2.11 Rest of Europe
  • 17.3 Asia Pacific
    • 17.3.1 China
    • 17.3.2 Japan
    • 17.3.3 India
    • 17.3.4 South Korea
    • 17.3.5 Australia
    • 17.3.6 Indonesia
    • 17.3.7 Thailand
    • 17.3.8 Malaysia
    • 17.3.9 Singapore
    • 17.3.10 Vietnam
    • 17.3.11 Rest of Asia Pacific
  • 17.4 South America
    • 17.4.1 Brazil
    • 17.4.2 Argentina
    • 17.4.3 Colombia
    • 17.4.4 Chile
    • 17.4.5 Peru
    • 17.4.6 Rest of South America
  • 17.5 Rest of the World (RoW)
    • 17.5.1 Middle East
      • 17.5.1.1 Saudi Arabia
      • 17.5.1.2 United Arab Emirates
      • 17.5.1.3 Qatar
      • 17.5.1.4 Israel
      • 17.5.1.5 Rest of Middle East
    • 17.5.2 Africa
      • 17.5.2.1 South Africa
      • 17.5.2.2 Egypt
      • 17.5.2.3 Morocco
      • 17.5.2.4 Rest of Africa

18 Strategic Market Intelligence

  • 18.1 Industry Value Network and Supply Chain Assessment
  • 18.2 White-Space and Opportunity Mapping
  • 18.3 Product Evolution and Market Life Cycle Analysis
  • 18.4 Channel, Distributor, and Go-to-Market Assessment

19 Industry Developments and Strategic Initiatives

  • 19.1 Mergers and Acquisitions
  • 19.2 Partnerships, Alliances, and Joint Ventures
  • 19.3 New Product Launches and Certifications
  • 19.4 Capacity Expansion and Investments
  • 19.5 Other Strategic Initiatives

20 Company Profiles

  • 20.1 CELLINK
  • 20.2 CollPlant Biotechnologies Ltd.
  • 20.3 Advanced BioMatrix
  • 20.4 Allevi, Inc.
  • 20.5 BIO INX
  • 20.6 Humabiologics, Inc.
  • 20.7 UPM Biomedicals
  • 20.8 Viscofan Bioengineering
  • 20.9 Inventia Life Science
  • 20.10 Axolotl Biosciences
  • 20.11 Foldink
  • 20.12 Merck KGaA
  • 20.13 TheWell Bioscience
  • 20.14 VoxCell BioInnovation
  • 20.15 Gelomics Pty Ltd.
  • 20.16 QGel SA
  • 20.17 INNOREGEN
  • 20.18 Scire Science

List of Tables

  • Table 1 Global Biofabrication Materials Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biofabrication Materials Market Outlook, By Material Type (2023-2034) ($MN)
  • Table 3 Global Biofabrication Materials Market Outlook, By Natural Biomaterials (2023-2034) ($MN)
  • Table 4 Global Biofabrication Materials Market Outlook, By Synthetic Biomaterials (2023-2034) ($MN)
  • Table 5 Global Biofabrication Materials Market Outlook, By Hybrid Biomaterials (2023-2034) ($MN)
  • Table 6 Global Biofabrication Materials Market Outlook, By Bioactive Biomaterials (2023-2034) ($MN)
  • Table 7 Global Biofabrication Materials Market Outlook, By Decellularized Extracellular Matrix Materials (2023-2034) ($MN)
  • Table 8 Global Biofabrication Materials Market Outlook, By Cell-Derived Biomaterials (2023-2034) ($MN)
  • Table 9 Global Biofabrication Materials Market Outlook, By Biomaterial Chemistry (2023-2034) ($MN)
  • Table 10 Global Biofabrication Materials Market Outlook, By Hydrogels (2023-2034) ($MN)
  • Table 11 Global Biofabrication Materials Market Outlook, By Natural Polymers (2023-2034) ($MN)
  • Table 12 Global Biofabrication Materials Market Outlook, By Synthetic Polymers (2023-2034) ($MN)
  • Table 13 Global Biofabrication Materials Market Outlook, By Proteins (2023-2034) ($MN)
  • Table 14 Global Biofabrication Materials Market Outlook, By Peptides (2023-2034) ($MN)
  • Table 15 Global Biofabrication Materials Market Outlook, By Polysaccharides (2023-2034) ($MN)
  • Table 16 Global Biofabrication Materials Market Outlook, By Ceramics (2023-2034) ($MN)
  • Table 17 Global Biofabrication Materials Market Outlook, By Composite Materials (2023-2034) ($MN)
  • Table 18 Global Biofabrication Materials Market Outlook, By Biofabrication Technology (2023-2034) ($MN)
  • Table 19 Global Biofabrication Materials Market Outlook, By 3D Bioprinting (2023-2034) ($MN)
  • Table 20 Global Biofabrication Materials Market Outlook, By 4D Bioprinting (2023-2034) ($MN)
  • Table 21 Global Biofabrication Materials Market Outlook, By Bioassembly (2023-2034) ($MN)
  • Table 22 Global Biofabrication Materials Market Outlook, By Cell Sheet Engineering (2023-2034) ($MN)
  • Table 23 Global Biofabrication Materials Market Outlook, By Microfluidic Biofabrication (2023-2034) ($MN)
  • Table 24 Global Biofabrication Materials Market Outlook, By Electrospinning (2023-2034) ($MN)
  • Table 25 Global Biofabrication Materials Market Outlook, By Bioprinting Technology (2023-2034) ($MN)
  • Table 26 Global Biofabrication Materials Market Outlook, By Extrusion-Based Bioprinting (2023-2034) ($MN)
  • Table 27 Global Biofabrication Materials Market Outlook, By Inkjet-Based Bioprinting (2023-2034) ($MN)
  • Table 28 Global Biofabrication Materials Market Outlook, By Laser-Assisted Bioprinting (2023-2034) ($MN)
  • Table 29 Global Biofabrication Materials Market Outlook, By Stereolithography-Based Bioprinting (2023-2034) ($MN)
  • Table 30 Global Biofabrication Materials Market Outlook, By Digital Light Processing Bioprinting (2023-2034) ($MN)
  • Table 31 Global Biofabrication Materials Market Outlook, By Volumetric Bioprinting (2023-2034) ($MN)
  • Table 32 Global Biofabrication Materials Market Outlook, By Bioink Type (2023-2034) ($MN)
  • Table 33 Global Biofabrication Materials Market Outlook, By Natural Polymer-Based Bioinks (2023-2034) ($MN)
  • Table 34 Global Biofabrication Materials Market Outlook, By Synthetic Polymer-Based Bioinks (2023-2034) ($MN)
  • Table 35 Global Biofabrication Materials Market Outlook, By Decellularized Matrix-Based Bioinks (2023-2034) ($MN)
  • Table 36 Global Biofabrication Materials Market Outlook, By Protein-Based Bioinks (2023-2034) ($MN)
  • Table 37 Global Biofabrication Materials Market Outlook, By Polysaccharide-Based Bioinks (2023-2034) ($MN)
  • Table 38 Global Biofabrication Materials Market Outlook, By Composite Bioinks (2023-2034) ($MN)
  • Table 39 Global Biofabrication Materials Market Outlook, By Cell-Laden Bioinks (2023-2034) ($MN)
  • Table 40 Global Biofabrication Materials Market Outlook, By Scaffold Type (2023-2034) ($MN)
  • Table 41 Global Biofabrication Materials Market Outlook, By Hydrogel Scaffolds (2023-2034) ($MN)
  • Table 42 Global Biofabrication Materials Market Outlook, By Porous Polymer Scaffolds (2023-2034) ($MN)
  • Table 43 Global Biofabrication Materials Market Outlook, By Decellularized Scaffolds (2023-2034) ($MN)
  • Table 44 Global Biofabrication Materials Market Outlook, By Ceramic Scaffolds (2023-2034) ($MN)
  • Table 45 Global Biofabrication Materials Market Outlook, By Composite Scaffolds (2023-2034) ($MN)
  • Table 46 Global Biofabrication Materials Market Outlook, By Nanofibrous Scaffolds (2023-2034) ($MN)
  • Table 47 Global Biofabrication Materials Market Outlook, By Cell Source (2023-2034) ($MN)
  • Table 48 Global Biofabrication Materials Market Outlook, By Autologous Cells (2023-2034) ($MN)
  • Table 49 Global Biofabrication Materials Market Outlook, By Allogeneic Cells (2023-2034) ($MN)
  • Table 50 Global Biofabrication Materials Market Outlook, By Xenogeneic Cells (2023-2034) ($MN)
  • Table 51 Global Biofabrication Materials Market Outlook, By Primary Cells (2023-2034) ($MN)
  • Table 52 Global Biofabrication Materials Market Outlook, By Stem Cells (2023-2034) ($MN)
  • Table 53 Global Biofabrication Materials Market Outlook, By Induced Pluripotent Stem Cells (2023-2034) ($MN)
  • Table 54 Global Biofabrication Materials Market Outlook, By Progenitor Cells (2023-2034) ($MN)
  • Table 55 Global Biofabrication Materials Market Outlook, By Cell Lines (2023-2034) ($MN)
  • Table 56 Global Biofabrication Materials Market Outlook, By Cell Type (2023-2034) ($MN)
  • Table 57 Global Biofabrication Materials Market Outlook, By Mesenchymal Stem Cells (2023-2034) ($MN)
  • Table 58 Global Biofabrication Materials Market Outlook, By Embryonic Stem Cells (2023-2034) ($MN)
  • Table 59 Global Biofabrication Materials Market Outlook, By Neural Cells (2023-2034) ($MN)
  • Table 60 Global Biofabrication Materials Market Outlook, By Cardiomyocytes (2023-2034) ($MN)
  • Table 61 Global Biofabrication Materials Market Outlook, By Hepatocytes (2023-2034) ($MN)
  • Table 62 Global Biofabrication Materials Market Outlook, By Chondrocytes (2023-2034) ($MN)
  • Table 63 Global Biofabrication Materials Market Outlook, By Osteoblasts (2023-2034) ($MN)
  • Table 64 Global Biofabrication Materials Market Outlook, By Endothelial Cells (2023-2034) ($MN)
  • Table 65 Global Biofabrication Materials Market Outlook, By Fibroblasts (2023-2034) ($MN)
  • Table 66 Global Biofabrication Materials Market Outlook, By Epithelial Cells (2023-2034) ($MN)
  • Table 67 Global Biofabrication Materials Market Outlook, By Immune Cells (2023-2034) ($MN)
  • Table 68 Global Biofabrication Materials Market Outlook, By Biofabricated Tissue (2023-2034) ($MN)
  • Table 69 Global Biofabrication Materials Market Outlook, By Skin (2023-2034) ($MN)
  • Table 70 Global Biofabrication Materials Market Outlook, By Bone (2023-2034) ($MN)
  • Table 71 Global Biofabrication Materials Market Outlook, By Cartilage (2023-2034) ($MN)
  • Table 72 Global Biofabrication Materials Market Outlook, By Muscle (2023-2034) ($MN)
  • Table 73 Global Biofabrication Materials Market Outlook, By Neural Tissue (2023-2034) ($MN)
  • Table 74 Global Biofabrication Materials Market Outlook, By Cardiovascular Tissue (2023-2034) ($MN)
  • Table 75 Global Biofabrication Materials Market Outlook, By Liver Tissue (2023-2034) ($MN)
  • Table 76 Global Biofabrication Materials Market Outlook, By Kidney Tissue (2023-2034) ($MN)
  • Table 77 Global Biofabrication Materials Market Outlook, By Pancreatic Tissue (2023-2034) ($MN)
  • Table 78 Global Biofabrication Materials Market Outlook, By Lung Tissue (2023-2034) ($MN)
  • Table 79 Global Biofabrication Materials Market Outlook, By Gastrointestinal Tissue (2023-2034) ($MN)
  • Table 80 Global Biofabrication Materials Market Outlook, By Corneal Tissue (2023-2034) ($MN)
  • Table 81 Global Biofabrication Materials Market Outlook, By Vascular Tissue (2023-2034) ($MN)
  • Table 82 Global Biofabrication Materials Market Outlook, By Material Property (2023-2034) ($MN)
  • Table 83 Global Biofabrication Materials Market Outlook, By Biocompatibility (2023-2034) ($MN)
  • Table 84 Global Biofabrication Materials Market Outlook, By Biodegradability (2023-2034) ($MN)
  • Table 85 Global Biofabrication Materials Market Outlook, By Bioactivity (2023-2034) ($MN)
  • Table 86 Global Biofabrication Materials Market Outlook, By Mechanical Strength (2023-2034) ($MN)
  • Table 87 Global Biofabrication Materials Market Outlook, By Cell Adhesion (2023-2034) ($MN)
  • Table 88 Global Biofabrication Materials Market Outlook, By Cell Proliferation (2023-2034) ($MN)
  • Table 89 Global Biofabrication Materials Market Outlook, By Cell Differentiation (2023-2034) ($MN)
  • Table 90 Global Biofabrication Materials Market Outlook, By Controlled Degradation (2023-2034) ($MN)
  • Table 91 Global Biofabrication Materials Market Outlook, By Stimuli Responsiveness (2023-2034) ($MN)
  • Table 92 Global Biofabrication Materials Market Outlook, By Application (2023-2034) ($MN)
  • Table 93 Global Biofabrication Materials Market Outlook, By Tissue Engineering (2023-2034) ($MN)
  • Table 94 Global Biofabrication Materials Market Outlook, By Regenerative Medicine (2023-2034) ($MN)
  • Table 95 Global Biofabrication Materials Market Outlook, By Drug Discovery and Development (2023-2034) ($MN)
  • Table 96 Global Biofabrication Materials Market Outlook, By Disease Modeling (2023-2034) ($MN)
  • Table 97 Global Biofabrication Materials Market Outlook, By Organ-on-a-Chip (2023-2034) ($MN)
  • Table 98 Global Biofabrication Materials Market Outlook, By Personalized Medicine (2023-2034) ($MN)
  • Table 99 Global Biofabrication Materials Market Outlook, By Cell-Based Assays (2023-2034) ($MN)
  • Table 100 Global Biofabrication Materials Market Outlook, By Wound Healing (2023-2034) ($MN)
  • Table 101 Global Biofabrication Materials Market Outlook, By Transplantation (2023-2034) ($MN)
  • Table 102 Global Biofabrication Materials Market Outlook, By End User (2023-2034) ($MN)
  • Table 103 Global Biofabrication Materials Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 104 Global Biofabrication Materials Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • Table 105 Global Biofabrication Materials Market Outlook, By Hospitals and Medical Centers (2023-2034) ($MN)
  • Table 106 Global Biofabrication Materials Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 107 Global Biofabrication Materials Market Outlook, By Medical Device Companies (2023-2034) ($MN)
  • Table 108 Global Biofabrication Materials Market Outlook, By Tissue Engineering Companies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.